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The aim of our study was to examine the influence of
administration of N6,2’-dibutyryladenosine 3’5’-cyclic monophosphate
(dbcAMP), a cAMP agonist, on ovarian folliculogenesis and atresia, as
well as on reproductive efficiency in rabbits, whose ovarian cycle and
ovulation was induced by gonadotropins.
Ovarian cycle and ovulation of control rabbits were induced by
20 IU/kg PMSG followed by 35 IU/kg hCG administration. Experimental
animals received PMSG and hCG together with dbcAMP (at 5, 25 or
50 g/animal). After ovulation and insemination, the animals were
sacrificed. Ovaries were weighted, histological sections of ovaries
were prepared, and the presence of ovulated and not ovulated follicles
and different stages of atresia was evaluated by light microscopy. The
eggs were flushed from the oviducts after insemination and cultured up
to blastocyst cell stage. Numbers of ovarian Corpora lutea, ovulated
oocytes and oocyte-derived zygotes and embryos reaching hatched
blastocyst stage were determined.
Administration of dbcAMP (at doses 25 or 50 g/animal, but not at
5 g/animal) was able to increase the proportion of follicles with cystic
and luteinization-related atresia. Furthermore, dbcAMP (50 g/animal,
but not lower doses) increased the ovarian mass, number of Corpora
lutea, number of harvested oocytes, zygotes and embryos at blastocyst
stage derived from these zygotes after culture.
These data demonstrate that dbcAMP can stimulate rabbit
ovarian follicle atresia, ovulation, oocyte, zygote and embryo yield and
development. Furthermore, they confirm in the involvement of cyclic
nucleotide-dependent intracellular mechanisms in the control of rabbit
reproductive functions and potential practical usefulness of dbcAMP in
improving animal reproduction and fertility.
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There is a growing body of evidence, that cyclic adenosine monophosphate
(cAMP) is involved in the control of ovarian functions.
The cAMP/cAMP-dependent protein kinase (PKA) system plays an
important role in the control of ovarian cell proliferation, apoptosis, secretory
activity, oocyte maturation and in mediating the effect of hormonal stimulators on
these processes (Makarevich and Sirotkin, 2000; Conti, 2002; Mehlmann, 2005;
Sirotkin, 2005; Hunzicker-Dunn and Maizels, 2006). Furthermore, cAMP can
mediate the effects of some hormonal stimulators on oviductal functions
(Makarevich and Sirotkin, 1997; Orihuella et al., 2003). Temporal changes in
cAMP activity, which can be regulated by pharmacological blockers of cAMP-
specific phosphodiesterases (PDEs, catalysers of cAMP degradation) can control
sexual maturation and ovarian cyclicity (Wang et al., 2007). Synthetic inhibitors of
cAMP-specific PDEs were able to increase cAMP accumulation in ovarian cells, as
well as number of ovulations, embryos and born pups in gonadotropin-stimulated
rats (McKenna et al., 2005). Administration of IBMX, the inhibitor of cAMP- and
cGMP-specific PDEs, stimulated rabbit ovarian follicullogenesis, affected ovarian
and oviduct cell proliferation, apoptosis and release of hormones (Sirotkin et al.,
2010b) and promoted ovulation and embryo production (Sirotkin et al., 2008,
2010a). These findings indicate, that pharmacological activators of cAMP/PKA
could be promising promoters of ovarian functions, as well as enhancers or even
alternative to classical hormonal stimulators of reproductive processes in
agriculture, human and veterinary medicine and assisted reproduction.
Nevertheless, the previous stimulation of reproductive processes in vivo via
cAMP/PKA was achieved only by administration of PDE inhibitors, which effect on
PKAisnotspecific(IBMXaffectsbothcAMPandcGMP)andindirect(viainhibition
of cyclic nucleotide degradation, but not via direct activation of cAMP and cGMP
targets). The effect of direct PKA activator, stabile and cell-permeable cAMP
analogue, N6,2’-dibutyryladenosine 3’5’-cyclic monophosphate (dbcAMP;
Posternak and Weiman, 1974), on rabbit ovarian steroidogenesis has been
observed (Chrenek et al., 2010c), but its action on reproduction and fertility have
not been previously studied yet.
The aim of our study was to examine the influence of administration of
dbcAMP on ovarian folliculogenesis, atresia and luteogenesis, as well as on the
reproductive efficiency (oocyte and zygote recovery end embryo yield and
development) in rabbits, whose ovarian cycle and ovulation was induced by
gonadotropins.
MATERIALS AND METHODS
Manipulations with animals and embryo production
Female New Zealand non-cycling rabbits (Oryctolagus cuniculus,
Leporidae, Lagomorpha) 4 months of age, were bred and kept in individual cages
under standard conditions at the local rabbit farm of Animal Production Research
Centre, Nitra, Slovakia. Three days before mating, rabbits were treated with
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Vienna, Austria, 20 IU/kg) followed after 72 h by human chorionic gonadotropin
(hCG, Werfachor, Alvetra und Werfft AG, 35 IU/kg). Control animals were treated
only with these gonadotropins, whilst experimental females received
gonadotropins together with dbcAMP (Life Science Institute, Bremen, Germany,
at 5, 25 or 50 g/animal). Gonadotropins and dbcAMP were dissolved in PBS
immediately before injection. All substances (0.7 mL solution of gonadotropin
with or without dbcAMP per animal) were injected intramuscularly. At 19-20h after
artificial insemination with freshly diluted sperm, the females were killed by
decapitation. The ovaries were collected, weighted, numbers of Corpora lutea in
both ovaries were determined by visual inspection, and the ovaries were
subjected to histological analysis (see below).
The pronuclear stage zygotes were flushed from the oviduct with PBS
supplemented with 10% FCS (Gibco BRL/Invitrogen Corp., Carlsbad, CA, USA)
and washed in CIM medium +10% FCS (Gibco BRL). The eggs were cultured in
k–DMEM+10%FBS(GibcoBRL)at5%CO2and39oCuptoblastocystcellstage.
Stages of embryogenesis were determined in different times of culture under a
stereomicroscope at 40- or 100-fold magnification. Detailed description of animal
and zygote treatment was published previously (Chrenek et al., 1999).
All experiments were carried out with the approval of a local ethical
commission in accordance to Slovak and EU regulations concerning animal
experiments.
Histological analysis
The ovaries were fixed 24 h in 10% formalin, washed 2 h in flowing water,
dehydratedin70%,96%and100%ethanol(2heach)andembeddedinparaffinor
Technovit 7100 (Heraeus Kulzer GmbH&CoKG, Wehrheim/Ts., Germany)
according to instruction of manufacturer. Thereafter the ovaries were serially
sectioned by using a standard rotation microtome at 5 or 10 m thickness. The
sections were subsequently dewaxed, rehydrated and stained with eosin-
haematoxylin or basic fuchsin-toluidin blue (Edward Gurr Ltd., London, UK) and
embedded to entelan (Merck, Darmstadt, Germany) according to Hayat (1993).
Two representative sectional profiles from the stained ovaries were examined and
photographed using an Jenaval (Carl Zeiss, Jena, Germany) light microscope. All
primary, secondary and tertiary ovulated follicles, as well as not ovulated follicles
at different stages of atresia were counted. The following stages of atresia were
identified: (1) no or small atresia (no visible pathological changes or some
disappearance of mitosis and appearance of nuclear vacuolisation), (2) obliteral
atresia (degeneration of granulosa layer and dominance of fibrocytes in theca
layer), (3) cystic atresia (disappearance of epithelial cells in both granulosa and
theca layers) and (4) atresia associated with luteinization (nuclear pyknosis, light
cytoplasm, cell hypertrophy and intensive multiplication of both granulosa and
theca cells. Histological sections of healthy follicles and follicles at different
stages of luteinization and atresia are shown in Fig.1.
Acta Veterinaria (Beograd), Vol. 62, No. 2-3, 227-237, 2012. 229
Chrenek P et al.: The cAMP analogue, dbcAMP can stimulate rabbit reproductive functions.
I. Effect on ovarian folliculogenesis, ovulation and embryo production230 Acta Veterinaria (Beograd), Vol. 62, No. 2-3, 227-237, 2012.
Chrenek P et al.: The cAMP analogue, dbcAMP can stimulate rabbit reproductive functions.
I. Effect on ovarian folliculogenesis, ovulation and embryo production
Figure 1. Histological sections of rabbit ovarian antral not ovulated follicles. Staining with
eosin-haematoxylin. Magnification x 300.
A: Healthy follicle (control group) with intact granulosa and theca externa and theca
interna cells (arrow).
B: First stages of atresia (control group). Interstitial cells (IC) are intact, some
granulose cells contain pyknotic nuclei, some granulosa cells are present in follicular
fluid (arrow).
C: Luteinization-associated atresia of follicle (treatment with dbcAMP , 50 µg/animal),
hypertrophy of both granulose and theca cells is visible (arrow).
D: Cystic atresia (control group). No epithelial granulose cells in the follicular wall
(arrow).
E: Hemorrhagic follicular cyst (asterisk). Some granulose cells with picnotic nuclei
are visible in both follicular wall and follicular fluid. Ovary of rabbit treated with
dbcAMP (50 µg/animal).
F: Hypertrophied luteinized granulosa and intestinal cells (IC) with pyknotic nuclei
(arrows). The large capillaries in intestinal layer are visible (asterisk). The ovary of
control animal.
A B
C D
E F
*
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Each experiment was performed on 4 control animals and 4 animals treated
with dbcAMP at each dose. Each animal from each group was killed, and ovaries
and embryos harvested for subsequent analysis. Each experiment was
performed 6 times. Histological data represent the data obtained by inspection of
slices from 6 ovaries per experiment. The data shown are means of values
obtained in 6 separate experiments performed in different days. Significant
differences between the groups were evaluated by one-way ANOVA followed by
paired t-test or chi-square test by using Sigma Plot 9.0 statistical software (Systat
Software, GmbH, Erkrath, Germany). Differences at p<0.05 were considered as
significant.
RESULTS
Administration of gonadotropins and subsequent mating of females
induced development and ovulation of their ovarian follicles, formation of Corpora
luthea, expulsion of oocytes into the oviduct, and subsequent embryo
development in vitro (see below).
Histological examination of ovaries after ovulation induced with either with
gonadotropins alone or gonadotropins in combination with dbcAMP revealed the
presence of ovulated and non-ovulated follicles. Some non-ovulated follicles had
signs of luteinization and atresia. Substantial part of ovarian follicles expressed
signs of obliteral atresia, cystic atresia and atresia associated with luteinisation.
Description of these morphological signs (reduced cell proliferation and
appearance of nuclear vacuolization, pyknosis of nuclei, degeneration and
disappearance of cells by obliteral and cystic atresia, degeneration the follicular
wall, nuclear picnosis, light cytoplasm, cell hypertrophy and intensive
multiplication of cells by luteinization and luteinization-associated atresia) is
present in Materials and Methods and illustrated in Fig.1.
Micromorphometric analysis of ovarian slices showed the influence of
dbcAMP treatment on the occurrence of some forms of follicular atresia of
different classes in the ovary (Table 1). Administration of dbcAMP tended to
increase percentage of ovulated follicles and decrease the proportion of non-
ovulated follicles, but these changes were statistically not significant. Injections of
dbcAMP did not substantially affect the proportion of non-ovulated follicles
without expressed atresia or with obliteral atresia. On the other hand, ovaries of
rabbits treated with dbcAMP at doses 25 and 50 g/animal, but not 5 g/animal,
had higher proportion of follicles with signs of cystic atresia. Moreover,
administration of dbcAMP at the dose of 25 g/animal, but not at other doses,
resulted in increased percentage of follicles with atresia associated with
luteinization.
Macromorphometric analysis of ovaries and subsequent evaluation of
oocyte and embryo yield and development demonstrated, that administration of
dbcAMP at doses 50, but not 5 or 25 g/animal significantly increased the ovarian
mass (Fig. 2a) number of Corpora luthea (Fig. 2b) in the ovaries of rabbits treated
with gonadotropins. Furthermore, dbcAMP , when administrated at this dose, but
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Figure 2. Effects of dbcAMP treatment (5, 25 or 50 g/animal) on reproductive parameters
in rabbit females: ovarian mass (a), number of Corpora lutea, (b), number of
harvested oocytes (c), zygotes (d), embryos reaching morula stage (e) and embryos
reaching blastocyst stage (f). Values are means±S.E.M., * – significant (p<0.05)
differences with control (no dbcAMP treatment)
Effect of dbcAMP administration on the
ovarian mass in rabbit plasma
*significant (p<0.05) differences with
control (no dbcAMP)
Effect of dbcAMP administration on the
number of Corpora lutea in rabbits
*significant (p<0.05) differences with
control (no dbcAMP)
Effect of dbcAMP administration on the
number of oocytes in rabbits
*significant (p<0.05) differences with
control (no dbcAMP)
Effect of dbcAMP administration on the
number of zygotes in rabbits
*significant (p<0.05) differences with
control (no dbcAMP)
Effect of dbcAMP administration on the
number of embryos reaching morula
stage in rabbits
*significant (p<0.05) differences with
control (no dbcAMP)
Effect of dbcAMP administration on the
number of embryos reaching hatched
blastocist stage in rabbits
*significant (p<0.05) differences with
control (no dbcAMP)
a) b)
c) d)
e) f)not at lower doses, significantly increased the number of harvested ovulated
oocytes (Fig. 2c), zygotes (Fig. 2d), embryos reaching the morula stage (Fig. 2e)
and later hatching the blastocyst stage (Fig.2f) derived from these zygotes after
culture.
Table 1. State of rabbit ovarian follicles after ovulation induced by gonadotropins
with and without dbcAMP given at different doses
Stage of follicullogenesis
Control
(no dbcAMP
treatment)
n/%
dbcAMP treatments at dose
5 µg/animal
n/%
25 µg/animal
n/%
50 µg/animal
n/%
All examined follicles 380/100 166/100 159/100 278/100
Follicles after ovulation 116/30,5 64/38,5 51/32,1 102/36,7
Not ovulated follicles total 264/69,5 102/61,4 108/68,6 176/63,3
Not ovulated follicles,
no or small atresia 76/28,8 26/25,5 25/23,1 45/25,6
Not ovulated follicles,
expressed obliteral atresia 51/19,3 21/20,6 19/17,6 34/19,3
Not ovulated follicles,
cystic atresia 23/8,7 9/8,8 21/19,4* 29/16,5*
Not ovulated follicles, atresia
associated with luteinisation 39/14,8 17/16,7 26/24,1* 36/20,4
Legend:
n – number of follicles at particular stage of folliculogenesis presented in ovaries;
% – percentage of follicles at particular stage of folliculogenesis versus total number of
follicles presented in ovaries;
* – significant (p<0.05) differences with control (no dbcAMP treatment).
DISCUSSION
The obtained results demonstrate the ability of dbcAMP addition to affect
ovarian functions of rabbits, which reproduction was stimulated with
gonadotropins. It was shown, that administration of dbcAMP can potentially
increase the percentage of ovulated follicles, although this increase determined
by histological analysis was statistically insignificant. Furthermore, this analysis
demonstrated, that dbcAMP treatment significantly promoted the occurrence of
cystic and luteinization-associated atresia in non-ovulated follicles after
gonadotropin treatment. These changes suggest, that dbcAMP can potentially
promote ovarian follicular luteinization and atresia. The dbcAMP-induced ovarian
cell luteinisation associated with increased proliferation and hypertrophy of cells
within the ovarian follicles observed in our experiments are in line with the ability of
cyclic nucleotides to promote ovarian cell proliferation, as reported previously
(Cheadleetal.,2008,Viegasetal.,2008).ThedbcAMP-inducedatresiaexpressed
in our experiments, correspond previous reports of promotion (Amsterdam et al.,
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effectsofdbcAMParesimilartotheeffectsof gonadotropins,knownpromotersof
ovarian follicles ovulation, luteinization and atresia (Hillier, 2001).
Macromorphometric analysis of ovaries and subsequent evaluation of
oocyte and embryo yield and development demonstrated, that administration of
dbcAMP can significantly increase the ovarian mass, number of Corpora luthea
and ovulated oocytes. These effects of dbcAMP are in line with the ability of PDE
inhibitors to increase the number of ovulations and Corpora lutea in rats
(McKenna et al., 2005) and rabbits (Sirotkin et al., 2008; 2010a) as reported
previously. These data confirm the previous data on involvement of cAMP/PKA-
dependent intracellular mechanisms in the stimulation of ovarian functions.
Furthermore, the present observations represent the first in vivo demonstration,
that dbcAMP can promote ovarian growth, ovulation and oocyte production.
Since these effects are similar to known effects of gonadotropins (Hillier, 2001), it
suggest that dbcAMP can have gonadotropin-like action on rabbit ovarian cells
functions. Moreover, the stimulatory effects of dbcAMP was expressed in rabbits
treated with gonadotropins. The additive stimulatory action of dbcAMP suggests,
thatthismoleculecanincreasetheactionofgonadotropinsonovarianfunctions.
It is well-known, that stimulation of ovaries by exogenous gonadotropins
can increase ovulation rate and number of ovulated oocytes, but decrease the
quality and developmental potential of harvested oocytes (Hillier, 2000; Craig et
al., 2007). In our experiments, administration of dbcAMP was able not only
significantly to increase the number of harvested oocytes but also the number of
fertilized oocytes (zygotes) and subsequent embryos reaching stages of morula
and hatching blastocysts after culture. Therefore, the stimulatory action of
dbcAMP on rabbit ovarian functions was not associated with negative effects on
quality of harvested oocytes and their ability to be fertilized and to develop to
embryos up to preimplantation (hatched blastocyst) stage.
Comparison of effects of dbcAMP given at different doses on both ovarian
histologicalindexesandreproductiveparametersshowed,thatlowdbcAMPdose
(5 g/animal) was not efficient at all. dbcAMP , when administrated at medium
dose (25 g/animal), was able to increase cystic and luteinization-associated
atresia of ovarian follicles detected by histological analysis, but these changes did
not result in significant changes in rabbit reproductive parameters. It suggests,
that medium (25 g/animal) dose of dbcAMP can potentially affect ovarian
functions and promote gonadotropin-induced atresia, but not stimulatory
gonadoitropin effects on ovarian functions. Finally, the dbcAMP , when
administrated at high (50 g/animal) dose, promoted cystic, but not luteinization-
associated atresia, as well as increased all reproductive indexes. It demonstrates,
that this dose of dbcAMP is high enough to promote not (or not only)
gonadotropin-induced follicular atresia, but also follicular development up to
ovulation and yield of oocytes and embryos of good quality. This suggests that
dbcAMP can control different reproductive events relatively independently and
that different ovarian targets have different sensitivity to the dbcAMP action.
From practical viewpoints, this is the first demonstration of the beneficial
influence of the cAMP agonist on farm animal reproduction on stimulation of
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harvested oocytes, zygotes and embryos without loss of their quality. Practical
application of this molecule and other promoters of cAMP/PKA-dependent
intracellular mechanisms as additional or alternative stimulator of reproduction in
assisted reproduction, animal production, human and veterinary medicine should
not to be excluded. Nevertheless, prior to practical application of synthetic cAMP
analogues in control of animal and human reproduction and fertility, some key
questions should be addressed. In our experiments, dbcAMP given at different
doses affected different reproductive parameters, and only one dose
(50 g/animal) was really efficient. The optimal dose for animals of different ages
from both physiological and economical viewpoints, should be chosen.
Mechanisms of dbcAMP action, including hormonal mechanisms, should be
elucidated. The cAMP-related substances should be tested on other species
(especially on large farm animals and human). Possible side-effects should be
carefully examined in large-scale and long-term studies. Nevertheless, the
present observations are the first demonstration, that cAMP analogue, in addition
to gonadotropins, could be successfully used for stimulation of rabbit ovarian
development, ovulation, oocytes and embryos production.
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ANALOG cAMP-a, dbcAMP MO@E DA STIMULI[E REPRODUKTIVNE FUNKCIJE
KUNI]A. I - UTICAJ NA FOLIKULOGENEZU U JAJNICIMA, OVULACIJU I
NASTANAK EMBRIONA
CHRENEK P, PIVKO J, MAKAREVICH AV, KUBOVI^OVÁ HELENA, BALAZI A
i SIROTKIN AV
SADR@AJ
Cilj na{ih ispitivanja je bio da se ispita uticaj aplikacije N6,2’-dibutiril-
adenozin 3’5’-cikli~nog monofosfata (dbcAMP), agoniste cAMP-a, na folikuloge-
nezu i atreziju u jajnicima, kao i na reproduktivnu efikasnost `enki kuni}a, kod ko-
jih su ovarijalni ciklus i ovulacija indukovani gonadotropinom.
Ovarijalniciklusiovulacijakontrolnih`enkikuni}asuindukovanisa20IU/kg
PMSG, i ne{to kasnije aplikovanjem 35 IU/kg hCG. @enke eksperimentalne grupe
su dobijale PMSG i hCG zajedno sa dbcAMP-om (5,25 ili 50 g/`ivotinji). Posle
ovulacije i inseminacije, `ivotinje su `rtvovane, a zatim je merena masa jajnika.
Svetlosnom mikroskopijom je vr{ena histolo{ka analiza i odre|ivano je prisustvo
ovuliranih i neovuliranih folikula i kao i folikula sa razli~itim stepenom atrezije.
Jajne }elije su posle inseminacije ispirane iz jajovoda i uzgajane do faze blasto-
cite. Utvr|ivan je broj corpora lutea na jajnicima, broj ovuliranih oocita i zigota iz-
dvojenih iz oocita kao i broj embriona koji su dostigli fazu blastocita
Aplikacija dbcAMP-a u dozama 25 or 50 g/`ivotinji (ali ne i 5 g/ `ivotinji) je
dovodila do pove}anja udela folikula sa cisti~nom atrezijom i atrezijom po-
vezanom sa luteinizacijom. Dodatno je dbcAMP u dozi od 50 g/ `ivotinja (ali ne i
u ni`im dozama) pove}avao masu jajnika, broj corpora lutea i broj dobijenih
oocita, zigota i embriona u stadijumu blastocista izolovanih od ovih zigota posle
kultivacije.
Ovi podaci ukazuju da dbcAMP mo`e da stimuli{e atreziju folikula jajnika
kod `enki kuni}a, ovulaciju, prinos i razvoj oocita, zigota i embriona. Dalje, oni
potvr|uju da su intracelularni mehanizmi zavisni od cikli~nih nukleotida uklju~eni
u kontrolu reproduktivnih funkcija `enki kuni}a i da dbcAMP-a ima potencijalnu
prakti~nu vrednost u pobolj{anju reprodukcije i plodnosti farmskih `ivotinja.
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